Civic Intelligence

Peptide Therapeutics Foundation

990EZ • Fiscal year 2014 • EIN 26-3728931

Jan 01, 2014 to Dec 31, 2014 • Filed on May 12, 2015

Organization ProfileWWW.PEPTIDETHERAPEUTICS.ORG
4245 Sorrento Valley BlvdSan Diego, CA 92121

(858) 657-1511

Siviq Scores

Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.

Liabilities / Assets

79th percentile

0.14x

Higher debt load relative to assets than 79% of similar nonprofits.

2014 filings • 501(c)3 • <$500k nonprofits • Source year 2014

Liabilities / Revenue

90th percentile

0.36x

Higher debt load relative to revenue than 90% of similar nonprofits.

2014 filings • 501(c)3 • <$500k nonprofits • Source year 2014

Net Margin

75th percentile

18%

Higher net margin than 75% of similar nonprofits.

2014 filings • 501(c)3 • <$500k nonprofits • Source year 2014

Top Officer Pay

74th percentile

$0

Higher top officer pay than 74% of similar nonprofits.

Top officer pay equals 0.0% of source-year revenue.

2014 filings • 501(c)3 • <$500k nonprofits • Source year 2014

Asset Growth

60th percentile

8.6%

Faster asset growth than 60% of similar nonprofits.

2014 filings • 501(c)3 • <$500k nonprofits • Annualized from 2013 to 2014

Revenue Growth

65th percentile

13%

Faster revenue growth than 65% of similar nonprofits.

2014 filings • 501(c)3 • <$500k nonprofits • Annualized from 2013 to 2014

Balance Sheet
Liabilities / Assets79th percentile

Assets

Up

$348,771

Up $27,498 (+8.6%) from 2013

Net Assets

Up

$298,852

Up $24,657 (+9.0%) from 2013

Liabilities

Up

$49,919

Up $2,841 (+6.0%) from 2013

Revenue And Expenses
Liabilities / Revenue90th percentileNet Margin75th percentile

Revenue

Up

$137,675

Up $15,346 (+13%) from 2013

Expenses

Up

$113,018

Up $11,311 (+11%) from 2013

Net Income

Up

$24,657

Up $4,035 (+20%) from 2013

Historical Trend

Balance Sheet Trend

Asset Growth60th percentile

The highlighted filing sits inside the broader history for assets, liabilities, and net assets.

$600K$400K$200K$0Assets 2013: $321,273Liabilities 2013: $47,078Net Assets 2013: $274,1952013Assets 2014: $348,771Liabilities 2014: $49,919Net Assets 2014: $298,8522014Assets 2015: $389,214Liabilities 2015: $58,059Net Assets 2015: $331,1552015Assets 2016: $404,349Liabilities 2016: $58,620Net Assets 2016: $345,7292016Assets 2017: $478,564Liabilities 2017: $67,800Net Assets 2017: $410,7642017Assets 2018: $433,418Liabilities 2018: $1,296Net Assets 2018: $432,1222018Assets 2019: $442,929Liabilities 2019: $431Net Assets 2019: $442,4982019Assets 2020: $442,709Liabilities 2020: $2,807Net Assets 2020: $439,9022020Assets 2021: $373,700Liabilities 2021: $197Net Assets 2021: $373,5032021Assets 2022: $281,743Liabilities 2022: $500Net Assets 2022: $281,2432022Assets 2023: $286,944Net Assets 2023: $286,9442023Assets 2024: $335,263Net Assets 2024: $335,2632024

Highlighted filing

2014

Assets$348,771
Liabilities$49,919
Net Assets$298,852
Open 2014 Filing

Operations Trend

Revenue Growth65th percentile

Revenue, expenses, and net income across loaded years, with this filing highlighted.

$200K$100K$0-$100KRevenue 2013: $122,329Expenses 2013: $101,707Net Income 2013: $20,6222013Revenue 2014: $137,675Expenses 2014: $113,018Net Income 2014: $24,6572014Revenue 2015: $142,758Expenses 2015: $110,455Net Income 2015: $32,3032015Revenue 2016: $136,200Expenses 2016: $121,626Net Income 2016: $14,5742016Revenue 2017: $172,574Expenses 2017: $107,539Net Income 2017: $65,0352017Revenue 2018: $127,978Expenses 2018: $106,620Net Income 2018: $21,3582018Revenue 2019: $121,265Expenses 2019: $110,889Net Income 2019: $10,3762019Revenue 2020: $43,680Expenses 2020: $46,276Net Income 2020: -$2,5962020Revenue 2021: $66,103Expenses 2021: $115,909Net Income 2021: -$49,8062021Revenue 2022: $110,022Expenses 2022: $129,463Net Income 2022: -$19,4412022Revenue 2023: $134,883Expenses 2023: $157,903Net Income 2023: -$23,0202023Revenue 2024: $174,477Expenses 2024: $144,680Net Income 2024: $29,7972024

Highlighted filing

2014

Revenue$137,675
Expenses$113,018
Net Income$24,657
Open 2014 Filing
Jump To
Filing Snapshot
Filing Period
Jan 1, 2014 to Dec 31, 2014
Signed
May 12, 2015
Return Version
2014v5.0
Gross Receipts
$137,675
Mission and Program Overview

Mission

The mission of peptide therapeutics foundation is to provide and promote public and charitable educational and informational programs, materials, research and discussion in the medical scientific field of peptide science and technology.

Program Services

DescriptionGrantsExpenses
HOLD A PEPTIDE THERAPEUTICS SYMPOSIUM TO BRING TOGETHER WORLD LEADERS FROM ACADEMIA, THE BIOPHARMACEUTICAL INDUSTRY, CMOS, CROS, AND INVESTORS INTERESTED IN ALL ASPECTS OF PEPTIDE R&D, INCLUDING DRUG DISCOVERY, SAFETY AND TOXICOLOGY, CLINICAL DEVELOMENT, MANUFACTURING, PHARMACEUTICAL DEVELOPMENT, FORMULATION, DRUG DELIVERY AND REGULATORY AFFAIRS. THE ORGANIZATION ALSO PROVIDED 23 POSTDOCTORAL FELLOWS WITH FREE REGISTRATION TO THE SYMPOSIUM.$0$0
Compensation and Service Providers
Top Officer Pay74th percentile

Employees

NameTitleFull / Part TimeBaseOtherTotal
YVONNE ANGELL PHDDirector, Peptide And Protein Chem-$0--
MARIA BEDNAREK PHDFellow And Head Of The Peptide-$0--
HANS-JOACHIM BOHM PHDGlobal Head Of Chemistry-$0--
RICHARD DIMARCHI PHDProfessor And Chairman Of Chemistry-$0--
SOUMITRA GHOSH PHDPresident-$0--
TORSTEN HOFFMANN PHDExecutive VP & CSO-$0--
RODNEY LAX PHDSenior Director Of Bus. Dev., Na-$0--
PANKAJ R PATELChairman & Managing Director-$0--
CLAUDIO SCHTEINGART PHDVP Of Science & Technology-$0--
ADRIENNE DAY PHDBoard Secretary & Treasurer-$0--
Filing and Contact Details

Filer

Filer Name
Peptide Therapeutics Foundation
EIN
26-3728931
Phone
8586571511
Address
4245 SORRENTO VALLEY BLVD, SAN DIEGO, CA 92121

Signing Officer

Name
Adrienne Day
Title
Treasurer
Phone
8586571511
Signed
2015-05-12
Discuss with paid preparer
Yes

Preparer

Firm
GOODSELL & COMPANY INC CPA'S
Address
3143 4TH AVENUE, SAN DIEGO, CA 92103
Preparer
Krystyna S Holc CPA
Phone
6192384343
Supplemental Narrative

Additional Explanations

Form 990-ez, Part I, Line 8 - Other Revenue

“Description: other revenue. Amount: 64.”

Form 990-ez, Part I, Line 16 - Other Expenses

“Description: symposium expenses. Amount: 90,267. Description: foundation maintenance. Amount: 7,285. Description: board expenses. Amount: 1,876. Description: miscellaneous. Amount: 90. Total to form 990-ez, line 16: 99,518.”

Form 990-ez, Part II, Line 26 - Other Liabilities

“Description: accrued symposium expense. Beg. Of year amount: 47,078. End of year amount: 49,919.”

Raw XML Appendix204 raw XML fields

This appendix keeps the raw XML leaves available for debugging and edge-case review. The human report above is the primary experience.

Path#Value
IRS990EZ/ActivitiesNotPreviouslyRptInd00
IRS990EZ/BooksInCareOfDetail/BusinessName/BusinessNameLine1Txt0THE ORGANIZATION
IRS990EZ/BooksInCareOfDetail/PhoneNum08586571511
IRS990EZ/BooksInCareOfDetail/USAddress/AddressLine1Txt04245 SORRENTO VALLEY BLVD
IRS990EZ/BooksInCareOfDetail/USAddress/CityNm0SAN DIEGO
IRS990EZ/BooksInCareOfDetail/USAddress/StateAbbreviationCd0CA
IRS990EZ/BooksInCareOfDetail/USAddress/ZIPCd092121
IRS990EZ/CashSavingsAndInvestmentsGrp/BOYAmt0321273
IRS990EZ/CashSavingsAndInvestmentsGrp/EOYAmt0348771
IRS990EZ/ChgMadeToOrgnzngDocNotRptInd00
IRS990EZ/ContributionsGiftsGrantsEtcAmt0104940
IRS990EZ/DirectIndirectPltclExpendAmt00
IRS990EZ/DonorAdvisedFndsInd00
IRS990EZ/EngagedInExcessBenefitTransInd00
IRS990EZ/ExcessOrDeficitForYearAmt024657
IRS990EZ/FeesAndOtherPymtToIndCntrctAmt013500
IRS990EZ/FiledScheduleAInd01
IRS990EZ/ForeignFinancialAccountInd00
IRS990EZ/ForeignOfficeInd00
IRS990EZ/Form990TotalAssetsGrp/BOYAmt0321273
IRS990EZ/Form990TotalAssetsGrp/EOYAmt0348771
IRS990EZ/GrossReceiptsAmt0137675
IRS990EZ/InfoInScheduleOPartIIIInd0X
IRS990EZ/InfoInScheduleOPartIIInd0X
IRS990EZ/InfoInScheduleOPartIInd0X
IRS990EZ/InfoInScheduleOPartVInd0X
IRS990EZ/LobbyingActivitiesInd00
IRS990EZ/MadeLoansToFromOfficersInd00
IRS990EZ/MethodOfAccountingAccrualInd0X
IRS990EZ/NetAssetsOrFundBalancesBOYAmt0274195
IRS990EZ/NetAssetsOrFundBalancesEOYAmt0298852
IRS990EZ/NetAssetsOrFundBalancesGrp/BOYAmt0274195
IRS990EZ/NetAssetsOrFundBalancesGrp/EOYAmt0298852
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt00.25
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt10.25
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt20.25
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt30.25
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt41.00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt50.25
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt60.25
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt70.25
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt80.25
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt92.00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt10
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt20
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt30
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt40
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt50
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt60
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt70
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt80
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt90
IRS990EZ/OfficerDirectorTrusteeEmplGrp/EmployeeBenefitProgramAmt00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/EmployeeBenefitProgramAmt10
IRS990EZ/OfficerDirectorTrusteeEmplGrp/EmployeeBenefitProgramAmt20
IRS990EZ/OfficerDirectorTrusteeEmplGrp/EmployeeBenefitProgramAmt30
IRS990EZ/OfficerDirectorTrusteeEmplGrp/EmployeeBenefitProgramAmt40
IRS990EZ/OfficerDirectorTrusteeEmplGrp/EmployeeBenefitProgramAmt50
IRS990EZ/OfficerDirectorTrusteeEmplGrp/EmployeeBenefitProgramAmt60
IRS990EZ/OfficerDirectorTrusteeEmplGrp/EmployeeBenefitProgramAmt70
IRS990EZ/OfficerDirectorTrusteeEmplGrp/EmployeeBenefitProgramAmt80
IRS990EZ/OfficerDirectorTrusteeEmplGrp/EmployeeBenefitProgramAmt90
IRS990EZ/OfficerDirectorTrusteeEmplGrp/ExpenseAccountOtherAllwncAmt00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/ExpenseAccountOtherAllwncAmt10
IRS990EZ/OfficerDirectorTrusteeEmplGrp/ExpenseAccountOtherAllwncAmt20
IRS990EZ/OfficerDirectorTrusteeEmplGrp/ExpenseAccountOtherAllwncAmt30
IRS990EZ/OfficerDirectorTrusteeEmplGrp/ExpenseAccountOtherAllwncAmt40
IRS990EZ/OfficerDirectorTrusteeEmplGrp/ExpenseAccountOtherAllwncAmt50
IRS990EZ/OfficerDirectorTrusteeEmplGrp/ExpenseAccountOtherAllwncAmt60
IRS990EZ/OfficerDirectorTrusteeEmplGrp/ExpenseAccountOtherAllwncAmt70
IRS990EZ/OfficerDirectorTrusteeEmplGrp/ExpenseAccountOtherAllwncAmt80
IRS990EZ/OfficerDirectorTrusteeEmplGrp/ExpenseAccountOtherAllwncAmt90
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm0YVONNE ANGELL PHD
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm1MARIA BEDNAREK PHD
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm2HANS-JOACHIM BOHM PHD
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm3RICHARD DIMARCHI PHD
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm4SOUMITRA GHOSH PHD
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm5TORSTEN HOFFMANN PHD
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm6RODNEY LAX PHD
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm7PANKAJ R PATEL
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm8CLAUDIO SCHTEINGART PHD
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm9ADRIENNE DAY PHD
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt0DIRECTOR, PEPTIDE AND PROTEIN CHEM
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt1FELLOW AND HEAD OF THE PEPTIDE
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt2GLOBAL HEAD OF CHEMISTRY
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt3PROFESSOR AND CHAIRMAN OF CHEMISTRY
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt4PRESIDENT
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt5EXECUTIVE VP & CSO
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt6SENIOR DIRECTOR OF BUS. DEV., NA
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt7CHAIRMAN & MANAGING DIRECTOR
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt8VP OF SCIENCE & TECHNOLOGY
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt9BOARD SECRETARY & TREASURER
IRS990EZ/OperateHospitalInd00
IRS990EZ/Organization501c3Ind0X
IRS990EZ/OrganizationDissolvedEtcInd00
IRS990EZ/OrganizationHadUBIInd00
IRS990EZ/OtherChangesInNetAssetsAmt00
IRS990EZ/OtherExpensesTotalAmt099518
IRS990EZ/OtherRevenueTotalAmt064
IRS990EZ/PartVIHghstPdCntrctProfSrvcTxt0NONE
IRS990EZ/PartVIOfCompOfHghstPdEmplTxt0NONE
IRS990EZ/PoliticalCampaignActyInd00
IRS990EZ/PrimaryExemptPurposeTxt0THE MISSION OF PEPTIDE THERAPEUTICS FOUNDATION IS TO PROVIDE AND PROMOTE PUBLIC AND CHARITABLE EDUCATIONAL AND INFORMATIONAL PROGRAMS, MATERIALS, RESEARCH AND DISCUSSION IN THE MEDICAL SCIENTIFIC FIELD OF PEPTIDE SCIENCE AND TECHNOLOGY.
IRS990EZ/ProgramServiceRevenueAmt032671
IRS990EZ/ProgramSrvcAccomplishmentGrp/DescriptionProgramSrvcAccomTxt0HOLD A PEPTIDE THERAPEUTICS SYMPOSIUM TO BRING TOGETHER WORLD LEADERS FROM ACADEMIA, THE BIOPHARMACEUTICAL INDUSTRY, CMOS, CROS, AND INVESTORS INTERESTED IN ALL ASPECTS OF PEPTIDE R&D, INCLUDING DRUG DISCOVERY, SAFETY AND TOXICOLOGY, CLINICAL DEVELOMENT, MANUFACTURING, PHARMACEUTICAL DEVELOPMENT, FORMULATION, DRUG DELIVERY AND REGULATORY AFFAIRS. THE ORGANIZATION ALSO PROVIDED 23 POSTDOCTORAL FELLOWS WITH FREE REGISTRATION TO THE SYMPOSIUM.
IRS990EZ/ProgramSrvcAccomplishmentGrp/GrantsAndAllocationsAmt00
IRS990EZ/ProgramSrvcAccomplishmentGrp/ProgramServiceExpensesAmt00
IRS990EZ/ProhibitedTaxShelterTransInd00
IRS990EZ/RelatedOrganizationCtrlEntInd00
IRS990EZ/SchoolOperatingInd00
IRS990EZ/StatesWhereCopyOfReturnIsFldCd0CA
IRS990EZ/SubjectToProxyTaxInd00
IRS990EZ/SumOfTotalLiabilitiesGrp/BOYAmt047078
IRS990EZ/SumOfTotalLiabilitiesGrp/EOYAmt049919
IRS990EZ/TanningServicesProvidedInd00
IRS990EZ/TaxImposedOnOrganizationMgrAmt00
IRS990EZ/TaxImposedUnderIRC4911Amt00
IRS990EZ/TaxImposedUnderIRC4912Amt00
IRS990EZ/TaxImposedUnderIRC4955Amt00
IRS990EZ/TaxReimbursedByOrganizationAmt00
IRS990EZ/TotalExpensesAmt0113018
IRS990EZ/TotalProgramServiceExpensesAmt00
IRS990EZ/TotalRevenueAmt0137675
IRS990EZ/TrnsfrExmptNonChrtblRltdOrgInd00
IRS990EZ/TypeOfOrganizationCorpInd0X
IRS990EZ/WebsiteAddressTxt0WWW.PEPTIDETHERAPEUTICS.ORG
IRS990ScheduleA/AmountsRcvdDsqlfyPersonGrp/TotalAmt00
IRS990ScheduleA/GiftsGrantsContrisRcvd509Grp/CurrentTaxYearAmt0104940
IRS990ScheduleA/GiftsGrantsContrisRcvd509Grp/CurrentTaxYearMinus1YearAmt077440
IRS990ScheduleA/GiftsGrantsContrisRcvd509Grp/CurrentTaxYearMinus2YearsAmt0114970
IRS990ScheduleA/GiftsGrantsContrisRcvd509Grp/CurrentTaxYearMinus3YearsAmt0139970
IRS990ScheduleA/GiftsGrantsContrisRcvd509Grp/CurrentTaxYearMinus4YearsAmt090000
IRS990ScheduleA/GiftsGrantsContrisRcvd509Grp/TotalAmt0527320
IRS990ScheduleA/GrossReceiptsAdmissionsGrp/CurrentTaxYearAmt032735
IRS990ScheduleA/GrossReceiptsAdmissionsGrp/CurrentTaxYearMinus1YearAmt042876
IRS990ScheduleA/GrossReceiptsAdmissionsGrp/CurrentTaxYearMinus2YearsAmt052819
IRS990ScheduleA/GrossReceiptsAdmissionsGrp/CurrentTaxYearMinus3YearsAmt057090
IRS990ScheduleA/GrossReceiptsAdmissionsGrp/CurrentTaxYearMinus4YearsAmt057763
IRS990ScheduleA/GrossReceiptsAdmissionsGrp/TotalAmt0243283
IRS990ScheduleA/InvestmentIncomeCYPct00.00000
IRS990ScheduleA/OtherIncome509Grp/CurrentTaxYearMinus1YearAmt02013
IRS990ScheduleA/OtherIncome509Grp/TotalAmt02013
IRS990ScheduleA/PubliclySupportedOrg509a2Ind0X
IRS990ScheduleA/PublicSupportCY509Pct00.99740
IRS990ScheduleA/PublicSupportPY509Pct00.98400
IRS990ScheduleA/PublicSupportTotal509Amt0770603
IRS990ScheduleA/SubstAndDsqlfyPrsnsTotGrp/TotalAmt00
IRS990ScheduleA/SubstantialContributorsAmtGrp/TotalAmt00
IRS990ScheduleA/ThirtyThrPctSuprtTestsCY509Ind0X
IRS990ScheduleA/Total509Grp/CurrentTaxYearAmt0137675
IRS990ScheduleA/Total509Grp/CurrentTaxYearMinus1YearAmt0120316
IRS990ScheduleA/Total509Grp/CurrentTaxYearMinus2YearsAmt0167789
IRS990ScheduleA/Total509Grp/CurrentTaxYearMinus3YearsAmt0197060
IRS990ScheduleA/Total509Grp/CurrentTaxYearMinus4YearsAmt0147763
IRS990ScheduleA/Total509Grp/TotalAmt0770603
IRS990ScheduleA/TotalSupportCalendarYearGrp/CurrentTaxYearAmt0137675
IRS990ScheduleA/TotalSupportCalendarYearGrp/CurrentTaxYearMinus1YearAmt0122329
IRS990ScheduleA/TotalSupportCalendarYearGrp/CurrentTaxYearMinus2YearsAmt0167789
IRS990ScheduleA/TotalSupportCalendarYearGrp/CurrentTaxYearMinus3YearsAmt0197060
IRS990ScheduleA/TotalSupportCalendarYearGrp/CurrentTaxYearMinus4YearsAmt0147763
IRS990ScheduleA/TotalSupportCalendarYearGrp/TotalAmt0772616
IRS990ScheduleB/ContributorInformationGrp/ContributorBusinessName/BusinessNameLine10RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorNum0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/AddressLine10RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/AddressLine20RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/City0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/State0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/ZIPCode0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/TotalContributionsAmt0RESTRICTED
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt0DESCRIPTION: OTHER REVENUE. AMOUNT: 64.
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt1DESCRIPTION: SYMPOSIUM EXPENSES. AMOUNT: 90,267. DESCRIPTION: FOUNDATION MAINTENANCE. AMOUNT: 7,285. DESCRIPTION: BOARD EXPENSES. AMOUNT: 1,876. DESCRIPTION: MISCELLANEOUS. AMOUNT: 90. TOTAL TO FORM 990-EZ, LINE 16: 99,518.
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt2DESCRIPTION: ACCRUED SYMPOSIUM EXPENSE. BEG. OF YEAR AMOUNT: 47,078. END OF YEAR AMOUNT: 49,919.
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc0FORM 990-EZ, PART I, LINE 8 - OTHER REVENUE
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc1FORM 990-EZ, PART I, LINE 16 - OTHER EXPENSES
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc2FORM 990-EZ, PART II, LINE 26 - OTHER LIABILITIES
TransferPrsnlBnftContractsDecl/DeclarationDesc0THE ORGANIZATION DID NOT, DURING THE YEAR, RECEIVE ANY FUNDS, DIRECTLY,OR INDIRECTLY, TO PAY PREMIUMS ON A PERSONAL BENEFIT CONTRACT.THE ORGANIZATION, DID NOT, DURING THE YEAR, PAY ANY PREMIUMS, DIRECTLY,OR INDIRECTLY, ON A PERSONAL BENEFIT CONTRACT.
ReturnHeader/BuildTS02016-02-25 16:41:14Z
ReturnHeader/BusinessOfficerGrp/DiscussWithPaidPreparerInd01
ReturnHeader/BusinessOfficerGrp/PersonNm0ADRIENNE DAY
ReturnHeader/BusinessOfficerGrp/PersonTitleTxt0TREASURER
ReturnHeader/BusinessOfficerGrp/PhoneNum08586571511
ReturnHeader/BusinessOfficerGrp/SignatureDt02015-05-12
ReturnHeader/Filer/BusinessName/BusinessNameLine1Txt0PEPTIDE THERAPEUTICS FOUNDATION
ReturnHeader/Filer/BusinessNameControlTxt0PEPT
ReturnHeader/Filer/EIN0263728931
ReturnHeader/Filer/PhoneNum08586571511
ReturnHeader/Filer/USAddress/AddressLine1Txt04245 SORRENTO VALLEY BLVD
ReturnHeader/Filer/USAddress/CityNm0SAN DIEGO
ReturnHeader/Filer/USAddress/StateAbbreviationCd0CA
ReturnHeader/Filer/USAddress/ZIPCd092121
ReturnHeader/PreparerFirmGrp/PreparerFirmEIN0331005644
ReturnHeader/PreparerFirmGrp/PreparerFirmName/BusinessNameLine1Txt0GOODSELL & COMPANY INC CPA'S
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/AddressLine1Txt03143 4TH AVENUE
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/CityNm0SAN DIEGO
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/StateAbbreviationCd0CA
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/ZIPCd092103
ReturnHeader/PreparerPersonGrp/PhoneNum06192384343
ReturnHeader/PreparerPersonGrp/PreparerPersonNm0KRYSTYNA S HOLC CPA
ReturnHeader/ReturnTs02015-05-12T11:00:34-05:00
ReturnHeader/ReturnTypeCd0990EZ
ReturnHeader/TaxPeriodBeginDt02014-01-01
ReturnHeader/TaxPeriodEndDt02014-12-31
ReturnHeader/TaxYr02014

Document Assets

No mirrored PDF or thumbnail assets are attached yet.

Filings

Displayed year

2014 • Form 990EZDetailed filing. Detailed filing data is available for this year.

Open filing
Assets
$348,771
Liabilities
$49,919
Net assets
$298,852
Revenue
$137,675
Expenses
$113,018
Net income
$24,657
Balance SheetOperations
YearAssetsLiabilitiesNet AssetsRevenueExpensesNet Income
2024Detailed filing. Detailed filing data is available for this year.$3.35$3.35$1.74$1.45$0.30
2023Detailed filing. Detailed filing data is available for this year.$2.87$2.87$1.35$1.58$0.23
2022Detailed filing. Detailed filing data is available for this year.$2.82$0.01$2.81$1.10$1.29$0.19
2021Detailed filing. Detailed filing data is available for this year.$3.74$0.00$3.74$0.66$1.16$0.50
2020Detailed filing. Detailed filing data is available for this year.$4.43$0.03$4.40$0.44$0.46$0.03
2019Detailed filing. Detailed filing data is available for this year.$4.43$0.00$4.42$1.21$1.11$0.10
2018Detailed filing. Detailed filing data is available for this year.$4.33$0.01$4.32$1.28$1.07$0.21
2017Detailed filing. Detailed filing data is available for this year.$4.79$0.68$4.11$1.73$1.08$0.65
2016Detailed filing. Detailed filing data is available for this year.$4.04$0.59$3.46$1.36$1.22$0.15
2015Detailed filing. Detailed filing data is available for this year.$3.89$0.58$3.31$1.43$1.10$0.32
2014Detailed filing. Detailed filing data is available for this year.$3.49$0.50$2.99$1.38$1.13$0.25
2013Detailed filing. Detailed filing data is available for this year.$3.21$0.47$2.74$1.22$1.02$0.21